TenderDekho Logo
GEM

Contract Bidding Open For Gliclazide MR 30mg Tab,Glipizide 5mf Tab,Tab Vildagliptin 50mg,Linagliptin 5mg Tab,Cap Tacrolimus 0 in CENTRAL DELHI, DELHI

Bid Publish Date

13-Dec-2024, 12:05 pm

Bid End Date

04-Jan-2025, 12:00 pm

Generate Docs

Progress

Issue13-Dec-2024, 12:05 pm
Technical01-Mar-2025, 8:33 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

33530

Category

Cap Tacrolimus 1mg prolonged release

Bid Type

Two Packet Bid

Categories 8

A tender has been published for Indian Army Gliclazide MR 30mg Tab, Glipizide 5mf Tab, Tab Vildagliptin 50mg, Linagliptin 5mg Tab, Cap Tacrolimus 0. 5mg prolonged release, Cap Tacrolimus 1mg prolonged release, Acyclovir Ophth Ointment 3percent ww in 5gm Tube, Ciprofloxacin 0. 3percent eye drops of 3mg ml bott of 5ml, Cyclosporine eye drop 0. 05percent bott of 3ml, Fluconazole 0. 3percent wv bott of 5ml, Flurbiprofen Sodium ophthalmic soln 0. 03percent vial of 5ml, Gatifloxacin 0. 3percent eye drop bott of 5ml in CENTRAL DELHI, DELHI. Quantity: 33530 by. Submission Deadline: 04-01-2025 12: 00: 00. Check eligibility and apply.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

No

Item Category

Gliclazide MR 30mg Tab , Glipizide 5mf Tab , Tab Vildagliptin 50mg , Linagliptin 5mg Tab , Cap Tacrolimus 0.5mg prolonged release , Cap Tacrolimus 1mg prolonged release , Acyclovir Ophth Ointment 3percent ww in 5gm Tube , Ciprofloxacin 0.3percent eye drops of 3mg ml bott of 5ml , Cyclosporine eye drop 0.05percent bott of 3ml , Fluconazole 0.3percent wv bott of 5ml , Flurbiprofen Sodium ophthalmic soln 0.03percent vial of 5ml , Gatifloxacin 0.3percent eye drop bott of 5ml

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENTINDIAN ARMY

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 5

GeM-Bidding-7243920.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 12 Items Sign in for GEM prices

#1

Gliclazide MR 30mg Tab

Gliclazide MR 30mg Tab

3,000 no Delivery: 15 days
#2

Glipizide 5mf Tab

Glipizide 5mf Tab

3,000 no Delivery: 15 days
#3

Tab Vildagliptin 50mg

Tab Vildagliptin 50mg

6,600 no Delivery: 15 days
#4

Linagliptin 5mg Tab

Linagliptin 5mg Tab

18,000 tab Delivery: 15 days
#5

Cap Tacrolimus 0.5mg prolonged release

Cap Tacrolimus 0.5mg prolonged release

600 no Delivery: 15 days
#6

Cap Tacrolimus 1mg prolonged release

Cap Tacrolimus 1mg prolonged release

600 no Delivery: 15 days
#7

Acyclovir Ophth Ointment 3percent ww in 5gm Tube

Acyclovir Ophth Ointment 3% w/w in 5gm Tube

120 tube Delivery: 15 days
#8

Ciprofloxacin 0.3percent eye drops of 3mg ml bott of 5ml

Ciprofloxacin 0.3% eye drops of 3mg/ml bott of 5ml

120 bott Delivery: 15 days
#9

Cyclosporine eye drop 0.05percent bott of 3ml

Cyclosporine eye drop 0.05% bott of 3ml

150 bott Delivery: 15 days
#10

Fluconazole 0.3percent wv bott of 5ml

Fluconazole 0.3%w/v bott of 5ml

30 bott Delivery: 15 days
#11

Flurbiprofen Sodium ophthalmic soln 0.03percent vial of 5ml

Flurbiprofen Sodium ophthalmic soln 0.03% vial of 5ml

1,200 amp Delivery: 15 days
#12

Gatifloxacin 0.3percent eye drop bott of 5ml

Gatifloxacin 0.3% eye drop bott of 5ml

110 bott Delivery: 15 days

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Additional Doc 1 (Requested in ATC)

8

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

9

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Corrigendum Updates

1 Update
#1

Update

06-Jan-2025

Extended Deadline

07-Jan-2025, 11:00 am

Opening Date

07-Jan-2025, 11:30 am

Technical Results

S.No Seller Item Date Status
1
GAGAN ASSOCIATES   Under PMA
-03-01-2025 20:33:46
2
LUCKYS PHARMA LAB PRIVATE LIMITED   Under PMA
-06-01-2025 17:46:38
3
M/S NEW WAVES   Under PMA
-05-01-2025 20:09:01
4
MEDROUTE PHARMACEUTICALS PRIVATE LIMITED   Under PMA
-06-01-2025 10:29:32
5
NEW LIFE MEDICOS   Under PMA
-30-12-2024 15:23:14
6
NUTRAKEM PHARMA   Under PMA
-16-12-2024 13:45:11
7
REKIN PHARMA PRIVATE LIMITED   Under PMA
-01-01-2025 21:17:37
8
SHRISHTI PHARMACEUTICAL & SURGICALS   Under PMA
-03-01-2025 19:53:17
9
SUKUN PHARMA   Under PMA
-27-12-2024 14:16:50
10
VANDANA MEDICO TRADERS   Under PMA
-06-01-2025 12:56:07

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for GEM/2024/B/5702294?

The eligibility requirements include being a registered entity with at least 3 years of past experience in supplying similar products to a Central/State Government or PSU, along with an average OEM turnover of ₹2 Lakh in the last three years.

What certificates are required for this tender?

Bidders must submit the following certificates: OEM Authorization Certificate, Bidder Turnover Certificates, and any other relevant documents as specified in the tender.

How do I register for participating in this tender?

To register, bidders must create an account on the relevant government e-marketplace platform, ensuring to complete all mandatory fields and submissions as required.

What document formats are accepted for submissions?

The tender documents must be submitted in PDF or other specified formats as referenced in the documentation guidelines.

What are the technical specifications needed for the pharmaceuticals?

Bidders must meet the technical specifications and quality standards set by the regulatory authorities, which are detailed in the BoQ documentation.

Are there any quality standards specified for the supplied products?

Yes, all supplied pharmaceuticals must adhere to quality benchmarks established by regulatory bodies relevant to healthcare products.

What are the Earnest Money Deposit (EMD) details?

The tender documentation indicates that no EMD is required for this bid, allowing for easier participation.

What are the performance security requirements post-award of contract?

While the specifics may vary based on the contract, general guidelines state that performance security may not be required for this tender as indicated in the documents.

What are the payment terms for the supplied products?

Payment terms are typically stipulated in the contract post-award, but bidders should ensure financial viability in their bids that meet government payment timelines.

What is the evaluation and selection process for this tender?

The evaluation process consists of an item-wise assessment of each bid based on financial aspects, technical compliance, and past performance quantiles.

How will I be notified of bidding results?

Bidders will receive a notification of results via the official government procurement platform indicating successful bids and any further instructions.

Are there any provisions related to MSEs in this tender?

Yes, the tender grants preferred benefits to Micro, Small, and Medium Enterprises, including exemptions from experience and turnover conditions under specific scenarios.

What are the benefits of 'Make in India' policies related to this tender?

The 'Make in India' policies provide preferences for local suppliers, promoting domestic sourcing and potentially favoring bids meeting local content requirements.

How do bidding timelines work?

Bidding timelines for the submission and opening of offers are specified in the tender documentation. Bidders should adhere to these timelines to ensure participation.